의료진프로필

Comprehensive Young Age Breast Cancer registry from clinical, genomics, and patient-reported outcomes measured with 15 years follow-up: the CHARM cohort profile

Kang, DB; Park, S; Kim, HJ; Lee, JS; Han, JY; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Cho, JH; Park, YH

Social support during re-entry period and long-term quality of life in breast cancer survivors: a 10-year longitudinal cohort study

Cho, H; Kang, DB; Shin, DW; Kim, N; Lee, SK; Lee, JE; Nam, SJ; Cho, J

Outcomes of whole breast radiation therapy in Asian breast cancer patients with prior cosmetic implants

Kim, N; Cho, WK; Park, W; Lee, JE; Nam, SJ; Kim, SW; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Ko, ES; Kim, H

Impact of Social Support during Diagnosis and Treatment on Disease Progression in Young Patients with Breast Cancer: A Prospective Cohort Study

Kang, D; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, J; Lee, SK; Kim, JY; Nam, SJ; Cho, J; Park, YH

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/ pertuzumab for HER2-positive breast cancer

Kim, N; Kim, JY; Park, W; Cho, WK; Kim, TG; Im, YH; Ahn, JS; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Park, YH; Kim, H

The Impact of HER2-Low Expression on Oncologic Outcomes in Hormone Receptor-Positive Breast Cancer

Park, WK; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Ryu, JM; Chae, BJ

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Jung, HH; Kim, JY; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

The Role of Post-Mastectomy Radiotherapy in T1-2N1 Breast Cancer Patients: Propensity Score Matched Analysis

Kim, K; Park, W; Kim, H; Cho, WK; Kim, N; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM

Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer

Shin, J; Kim, JY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, W; Park, YH; Ahn, JS; Im, YH

Risk factors of breast cancer recurrence in pathologic complete response achieved by patients following neoadjuvant chemotherapy: a single-center retrospective study

Choi, JY; Woen, D; Jang, SY; Lee, H; Shin, DS; Kwak, Y; Lee, H; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Analysis of Prognoses according to Breast MRI Results in Patients with Axillary Lymph Node Metastases from an Unknown Primary Origin

Choi, ER; Woo, OH; Ko, EY; Han, BK; Choi, JS; Ko, ES; Kim, H; Kim, MK; Lee, JE

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy

Choi, HJ; Lee, JH; Jung, CS; Ryu, JM; Chae, BJ; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE; Jung, YJ; Kim, HY

Pretreatment endocrine symptoms and recurrence-free survival among young premenopausal patients with breast cancer: a prospective cohort study

Kang, DB; Cho, JH; Park, S; Kim, HJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Kim, JY; Nam, SJ; Park, YH

Prediction Model for Postoperative Quality of Life Among Breast Cancer Survivors Along the Survivorship Trajectory From Pretreatment to 5 Years: Machine Learning-Based Analysis

Kang, D; Kim, H; Cho, J; Kim, Z; Chung, M; Lee, JE; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Lee, SK

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer

Kim, JY; Park, S; Cho, EY; Lee, JE; Jung, HH; Chae, BJ; Kim, SW; Nam, SJ; Cho, SY; Park, YH; Ahn, JS; Lee, S; Im, YH

Trends of axillary surgery in breast cancer patients with axillary lymph node metastasis: a comprehensive single-center retrospective study

Kim, YJ; Kim, HJ; Chung, SY; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Progesterone Receptor Expression Level Predicts Prognosis of Estrogen Receptor-Positive/HER2-Negative Young Breast Cancer: A Single-Center Prospective Cohort Study

Kwak, Y; Jang, SY; Choi, JY; Lee, H; Shin, DS; Park, YH; Kim, JY; Ahn, JS; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Partridge, AH; Niman, SM; Ruggeri, M; Peccatori, FA; Azim, HA; Colleoni, M; Saura, C; Shimizu, C; Saetersdal, AB; Kroep, JR; Mailliez, A; Warner, E; Borges, VF; Amant, F; Gombos, A; Kataoka, A; Rousset-Jablonski, C; Borstnar, S; Takei, J; Lee, JE; Walshe, JM; Ruiz-Borrego, M; Moore, HCF; Saunders, C; Bjelic-Radisic, V; Susnjar, S; Cardoso, F; Smith, KL; Ferreiro, T; Ribi, K; Ruddy, K; Kammler, R; El-Abed, S; Viale, G; Piccart, M; Korde, LA; Goldhirsch, A; Gelber, RD; Pagani, O

Diagnostic Value of FDG PET/CT in Surveillance after Curative Resection of Breast Cancer

Lee, H; Choi, JY; Park, YH; Lee, JE; Kim, SW; Nam, SJ; Cho, YS

Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level

Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH

Effectiveness of Self-Assessment, TAilored Information, and Lifestyle Management for Cancer Patients? Returning to Work (START): A Multi-center, Randomized Controlled Trial

Kang, DB; Bae, KR; Ahn, Y; Kim, N; Nam, SJ; Lee, JE; Lee, SK; Shim, YM; Sinn, DH; Oh, SY; Chun, M; Heo, J; Cho, JH

Epidemiology of Second Non-breast Primary Cancers among Survivors of Breast Cancer: A Korean Population-Based Study by the SMARTSHIP Group

Kim, H; Kim, SS; Lee, JS; Yoon, JS; Youn, HJ; Shin, H; Lee, JE; Lee, SK; Chung, IY; Jung, SY; Choi, YJ; Cho, J; Woo, SU

Chemokine (C-C motif) Ligand 2 Is Regulated Through the EGFR/Src Pathway in HER2-positive Breast Cancer Cells

You, D; Kim, H; Jeong, Y; Yoon, SY; Lo, EJ; Lee, JE; Kim, S

Clinical Characteristics and Prognosis of Metaplastic Breast Cancer Compared with Invasive Ductal Carcinoma: A Propensity-Matched Analysis

Lee, JH; Ryu, JM; Lee, SK; Chae, BJ; Lee, JE; Kim, SW; Nam, SJ; Yu, J

The efficacy and safety of an indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: A multicenter, randomized, open-label, parallel phase 3 clinical trial

Bang, YJ; Choi, HJ; Kim, I; Lee, MH; Lee, SY; Shin, HJ; Nam, SJ; Lee, JE; Chae, BJ; Lee, SK; Ryu, JM; Kim, SW

The use of absorbable skin stapler in mastectomy does not increase the rate of surgical site infection

Lee, J; Lee, JE; Ryu, JM; Kim, SW; Nam, SJ; Yu, JH

Suppression of Platelet-Derived Growth Factor Receptor-Alpha Overcomes Resistance to Trastuzumab through STAT3-Dependent IL-6 Reduction in HER2-Positive Breast Cancer Cells

Kim, S; Kim, H; Jeong, Y; You, D; Yoon, SY; Lo, EJ; Nam, SJ; Lee, JE; Kim, SW

Feasibility of Ultrasound-Guided Localization for Clipped Metastatic Axillary Lymph Nodes After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Pilot Study

Kim, H; Ko, EY; Han, BK; Ko, ES; Choi, JS; Lee, JE; Cho, SY

Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages

You, D; Kim, H; Jeong, Y; Yoon, SY; Lo, E; Kim, S; Lee, JE

Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1)

Imoto, S; Wang, K; Bi, XW; Liu, GY; Im, YH; Im, SA; Sim, SH; Ueno, T; Futamura, M; Toi, M; Fujiwara, Y; Ahn, SG; Lee, JE; Park, YH; Takao, S; Oba, MS; Kitagawa, Y; Nishiyama, M

Comprehensive clinical characterization of patients with BRCA1: c.5017_5019del germline variant

Bang, YJ; Kwon, WK; Kim, JW; Lee, JE; Jung, BY; Kim, M; Kim, J; An, J; Jung, SP; Kim, HK; Kim, Z; Youn, HJ; Ryu, JM; Kim, SW

Association of Fat Graft with Breast Cancer Recurrence in Implant-Based Reconstruction: Does the Timing Matter?

Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, J; Kim, SW; Lee, JE; Ryu, JM; Bang, SI

ASO Visual Abstract: Association of Fat Graft in Implant-Based Reconstruction with Breast Cancer Recurrence: Does the Timing Matter?

Lee, KT; Kim, JH; Jeon, BJ; Pyon, JK; Mun, GH; Lee, SK; Yu, JH; Kim, SW; Lee, JE; Ryu, JM; Bang, SI

Predicting the Response of Neoadjuvant Chemotherapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer With Axillary Lymph Node Metastasis by Multigene Assay

Lee, JH; Ryu, JM; Ahn, JH; Cho, SY; Lee, SK; Yu, J; Chae, BJ; Nam, SJ; Han, J; Lee, JE; Kim, SW

Suggestion for the omission of post-mastectomy chest wall radiation therapy in patients who underwent skin-sparing/ nipple-sparing mastectomy

Kim, N; Park, W; Cho, WK; Kim, HY; Choi, DH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Chae, BJ; Lee, SK; Ryu, JM; Mun, GH; Pyon, JK; Jeon, BJ

Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?

Choi, HJ; Ryu, JM; Lee, JH; Bang, Y; Oh, J; Chae, BJ; Nam, SJ; Kim, SW; Lee, JE; Lee, SK; Yu, J

Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer

Kim, KE; Ko, EY; Han, BK; Ko, ES; Choi, JS; Kim, H; Lee, JE; Lee, H

Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort

Jo, H; Park, S; Kim, HR; Kim, H; Hong, J; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Oh, SY; Choi, SJ; Kim, JY; Ahn, JS; Im, YH; Nam, EM; Nam, SJ; Park, YH

Factors Affecting Pathologic Complete Remission in Patients with Hormone Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

Choi, HJ; Lee, JH; Jung, CS; Lee, JE; Jung, YJ; Lee, SJ; Kang, SK; Kim, HY

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/ Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience

Kim, JY; Nam, SJ; Lee, JE; Yu, J; Chae, BJ; Lee, SK; Ryu, JM; Ahn, JS; Im, YH; Kim, SW; Park, YH

ASO Visual Abstract: Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction-International Multicenter Pooled Data Analysis

Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A

Comparison of Recurrence Rate Between Re-Excision With Radiotherapy and Radiotherapy-Only Groups in Surgical Margin Involvement of In Situ Carcinoma

Lee, JH; Lee, H; Bang, YJ; Ryu, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Validation of Korean Version of the COmprehensive Score for Financial Toxicity (COST) among Breast Cancer Survivors

Shim, S; Kang, D; Kim, N; Han, G; Lim, J; Kim, H; Park, J; Lee, M; Lee, JE; Kim, SW; Yu, J; Chae, BJ; Ryu, JM; Nam, SJ; Lee, SK; Cho, J

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients

Bang, YJ; Kwon, WK; Nam, SJ; Kim, SW; Chae, BJ; Lee, SK; Ryu, JM; Kim, JW; Yu, J; Lee, JE

Discovery of BRCA1/BRCA2 founder variants by haplotype analysis

Kwon, WK; Jang, HJ; Lee, JE; Park, YH; Ryu, JM; Yu, J; Jang, JH; Kim, JW

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy

Kim, JY; Oh, JM; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kim, K; Im, YH

Surgical margin status and survival outcomes of breast cancer patients treated with breast-conserving surgery and whole-breast irradiation after neoadjuvant chemotherapy

Cheun, JH; Lee, YJ; Lee, JH; Shin, Y; Chun, JW; Baek, SY; Kim, HK; Lee, HB; Yu, J; Chae, BJ; Han, W; Lee, JE

Primary Angiosarcoma of the Breast: A Single-Center Retrospective Study in Korea

Kim, YJ; Ryu, JM; Lee, SK; Chae, BJ; Kim, SW; Nam, SJ; Yu, JH; Lee, JE

Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis

Park, HS; Lee, J; Lai, HW; Park, JM; Ryu, JM; Lee, JE; Kim, JY; Marrazzo, E; De Scalzi, AM; Corso, G; Montemurro, F; Gazzetta, G; Pozzi, G; Toesca, A

Relationship Between Breast and Axillary Pathologic Complete Response According to Clinical Nodal Stage: A Nationwide Study From Korean Breast Cancer Society

Ryu, JM; Choi, HJ; Park, EH; Kim, JY; Lee, YJ; Park, S; Lee, J; Park, HK; Nam, SJ; Kim, SW; Lee, JH; Lee, JE

Measurement of Perfusion Heterogeneity within Tumor Habitats on Magnetic Resonance Imaging and Its Association with Prognosis in Breast Cancer Patients

Cho, HH; Kim, H; Nam, SY; Lee, JE; Han, BK; Ko, EY; Choi, JS; Park, H; Ko, ES

Impact of Skeletal Muscle Loss and Visceral Obesity Measured Using Serial CT on the Prognosis of Operable Breast Cancers in Asian Patients

Kwon, MR; Ko, ES; Park, MS; Jeong, WK; Hwang, NY; Kim, JH; Lee, JE; Kim, SW; Yu, JH; Han, BK; Ko, EY; Choi, JS; Park, KW

Histologic analysis according to HER2 gene status in HER2 2+invasive breast cancer: a study of 280 cases comparing ASCO/CAP 2013 and 2018 guideline recommendations

Hwang, HW; Hong, SA; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

Immediate breast reconstruction has no impact on the oncologic outcomes of patients treated with post-mastectomy radiation therapy: a comparative analysis based on propensity score matching

Kim, N; Kim, H; Park, W; Choi, DH; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Yu, J; Lee, SK; Jeon, BJ; Pyon, JK; Mun, GH; Kim, TG

Risk of non-Hodgkin lymphoma in breast cancer survivors: a nationwide cohort study

Kang, D; Yoon, SE; Shin, D; Lee, J; Hong, YS; Lee, SK; Lee, JE; Park, YH; Ahn, JS; Guallar, E; Kim, WS; Lee, J; Kim, SJ; Cho, J

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

Jung, HH; Kim, JY; Cho, EY; Oh, JM; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Is Sentinel Lymph Node Biopsy for Breast Cancer with Cytology-Proven Axillary Metastasis Safe? A Prospective Single-Arm Study

Choi, HJ; Ryu, JM; Chae, BJ; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea

Park, YH; Karantza, V; Calhoun, SR; Park, S; Lee, S; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Nam, SJ; Aktan, G; Marsico, M

Breast Biopsy in Korea: A 10-Year Follow-Up Experience

Cha, SY; Ko, EY; Han, BK; Ko, ES; Choi, JS; Park, KW; Lee, JE

Effect of Poloxamer-Based Thermo- Sensitive Sol-Gel Agent on Upper Limb Dysfunction after Axillary Lymph Node Dissection: A Double-Blind Randomized Clinical Trial

Choi, HJ; Ryu, JM; Chae, BJ; Kim, EK; Min, JW; Shin, HJ; Nam, SJ; Yu, J; Lee, JE; Lee, SK; Kim, SW

Effect of mind and body education on quality of life among young breast cancer patients: a randomized controlled trial

Kang, D; Lee, JK; Kim, N; Kim, S; Lee, SK; Lee, JE; Nam, SJ; Cho, J

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

Partridge, AH; Niman, SM; Ruggeri, M; Peccatori, FA; Azim, HA; Colleoni, M; Saura, C; Shimizu, C; Saetersdal, AB; Kroep, JR; Mailliez, A; Warner, E; Borges, VF; Amant, F; Gombos, A; Kataoka, A; Rousset-Jablonski, C; Borstnar, S; Takei, J; Lee, JE; Walshe, JM; Borrego, MR; Moore, HC; Saunders, C; Cardoso, F; Susnjar, S; Bjelic-Radisic, V; Smith, KL; Piccart, M; Korde, LA; Goldhirsch, A; Gelber, RD; Pagani, O

Deep learning from HE slides predicts the clinical benefit from adjuvant chemotherapy in hormone receptor-positive breast cancer patients

Cho, SY; Lee, JH; Ryu, JM; Lee, JE; Cho, EY; Ahn, CH; Paeng, K; Yoo, I; Ock, CY; Song, SY

Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients

Woo, J; Gwak, G; Park, I; Bae, BN; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Prediction of pathologic complete response to neoadjuvant chemotherapy using machine learning models in patients with breast cancer

Kim, JY; Jeon, E; Kwon, S; Jung, H; Joo, S; Park, Y; Lee, SK; Lee, JE; Nam, SJ; Cho, EY; Park, YH; Ahn, JS; Im, YH

Changes in Korean National Healthcare Insurance Policy and Breast Cancer Surgery Trend in Korea

Rayzah, M; Ryu, JM; Lee, JH; Nam, SJ; Kim, SW; Lee, SK; Yu, J; Lee, KT; Bang, SI; Mun, GH; Pyon, JK; Jeon, BJ; Lee, JE

Validation of the Clinical Treatment Score Post-Five Years in Breast Cancer Patients for Predicting Late Distant Recurrence: A Single-Center Investigation in Korea

Lee¹, JH; Lee, SK; Chae, BJ; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Ryu, JM

Celastrol attenuates the inflammatory response by inhibiting IL-1 beta expression in triple-negative breast cancer cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE; Kim, S

YAP, CTGF and Cyr61 are overexpressed in tamoxifen-resistant breast cancer and induce transcriptional repression of ER alpha

Kim¹, H; Son, S; Ko, Y; Lee, JE; Kim, S; Shin, I

Entelon(R) (Vitis vinifera Seed Extract) Prevents Cancer Metastasis via the Downregulation of Interleukin-1 Alpha in Triple-Negative Breast Cancer Cells

You¹, D; Jeong, Y; Yoon, SY; Kim, SA; Lo, E; Kim, SW; Lee, JE; Nam, SJ; Kim, S

Deep Learning-Based Prediction Model for Breast Cancer Recurrence Using Adjuvant Breast Cancer Cohort in Tertiary Cancer Center Registry

Kim¹, JY; Lee, YS; Yu, J; Park, Y; Lee, SK; Lee, M; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Kang, M; Im, YH

Inhibition of platelet-derived growth factor receptor synergistically increases the pharmacological effect of tamoxifen in estrogen receptor alpha positive breast cancer

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Lee, JE

The efficacy and safety of indocyanine green-hyaluronic acid mixture (LuminoMark (TM)) for localization in patients with non-palpable breast lesions: a multi-center open-label parallel phase-2 clinical trial

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Lee, JE; Nam, SJ; Shin, HJ; Kim, SW

Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Lee, JE

Validation of the GenesWell BCT Score in Young Asian Women With HR+/HER2-Early Breast Cancer

Kwon¹, MJ; Ryu, JM; Cho, SY; Nam, SJ; Kim, SW; Lee, J; Lee, SJ; Park, JY; Park, HY; Hong, S; Kim, K; Han, J; Moon, Y; Shin, YK; Lee, JE

Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer

Min¹, SK; Lee, SK; Woo, J; Jung, SM; Ryu, JM; Yu, J; Lee, JE; Kim, SW; Chae, BJ; Nam, SJ

Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer

Woo¹, J; Ryu, JM; Jung, SM; Choi, HJ; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Chae, BJ

Does chemotherapy or radiotherapy affect the postoperative complication in breast cancer patients who underwent immediate breast reconstruction with tissue expander?

Jung¹, SM; Jeon, BJ; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Pyon, JK; Mun, GH; Bang, SI; Lee, JE

Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome

Park¹, YH; Lal, S; Lee, JE; Choi, YL; Wen, J; Ram, S; Ding, Y; Lee, SH; Powell, E; Lee, SK; Yu, JH; Ching, KA; Nam, JY; Kim, SW; Nam, SJ; Kim, JY; Cho, SY; Park, S; Kim, J; Hwang, S; Kim, YJ; Bonato, V; Fernandez, D; Deng, S; Wang, S; Shin, H; Kang, ES; Park, WY; Rejto, PA; Bienkowska, J; Kan, Z

Trends in Risk-Reducing Mastectomy and Risk-Reducing Salpingo-Oophorectomy in Korean Carriers of the BRCA1/2 Mutation

Jung¹, SM; Ryu, JM; Park, HS; Park, JS; Kang, E; Lee, S; Lee, HB; Youn, HJ; Yoo, TK; Kim, J; Lee, JE; Han, SA; Kim, D; Kim, SW

Association of the Implant Surface Texture Used in Reconstruction With Breast Cancer Recurrence

Lee¹, KT; Kim, S; Jeon, BJ; Pyon, JK; Mun, GH; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Nam, SJ; Bang, SI

Is the intraoperative frozen section analysis of sentinel lymph nodes necessary in clinically negative node breast cancer?

Jung¹, SM; Woo, J; Ryu, JM; Lee, SK; Chae, BJ; Yu, J; Kim, SW; Nam, SJ; Kim, EJ; Lee, JE

Isoflavone intake on the risk of overall breast cancer and molecular subtypes in women at high risk for hereditary breast cancer

Sim¹, EJ; Ko, KP; Ahn, C; Park, SM; Surh, YJ; An, S; Kim, SW; Lee, MH; Lee, JW; Lee, JE; Kim, KS; Yom, CK; Kim, HA; Park, SK

WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yoon, SY; Kim, SA; Kim, SW; Nam, SJ; Lee, JE

ANK2 Hypermethylation in Canine Mammary Tumors and Human Breast Cancer

Schabort¹, JJ; Nam, AR; Lee, KH; Kim, SW; Lee, JE; Cho, JY

Application of an open-chamber multi-channel microfluidic device to test chemotherapy drugs

Moon¹, HS; Yoo, CE; Kim, S; Lee, JE; Park, WY

Distribution of tumor subtypes in bilateral breast cancer Comparison between synchronous and metachronous cancer

Kim¹, H; Lee, H; Choi, DH; Park, W; Cho, WK; Nam, SJ; Lee, JE; Kim, SW; Lee, SK; Cho, EY; Cho, SY

Serum Vitamin Levels and Their Relationships with Other Biomarkers in Korean Breast Cancer Patients

Kim¹, JA; Choi, R; Won, H; Kim, S; Choi, HJ; Ryu, JM; Lee, SK; Yu, J; Kim, SW; Lee, JE; Lee, SY

Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer

Park¹, S; Lee, E; Park, S; Lee, S; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Kim, JY; Ahn, JS; Im, YH; Park, WY; Park, K; Park, YH

Impact of Serum Lipid on Breast Cancer Recurrence

Jung¹, SM; Kang, D; Guallar, E; Yu, J; Lee, JE; Kim, SW; Nam, SJ; Cho, J; Lee, SK

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

Prognostication of a 13-immune-related-gene signature in patients with early triple-negative breast cancer

Kim¹, JY; Jung, HH; Sohn, I; Woo, SY; Cho, H; Cho, EY; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Clinicopathological Features of Patients with the BRCA1 c.5339T > C (p.Leu1780Pro) Variant

Park¹, HS; Ryu, JM; Park, JS; Im, SA; Jung, SY; Kim, EK; Park, WC; Min, JW; Lee, J; You, JY; Lee, JE; Kim, SW

Surgical impact on anxiety of patients with breast cancer: 12-month follow-up prospective longitudinal study

Kim¹, J; Cho, J; Lee, SK; Choi, EK; Kim, IR; Lee, JE; Kim, SW; Nam, SJ

Influence of complications following total mastectomy and immediate reconstruction on breast cancer recurrence

Lee¹, KT; Jung, JH; Mun, GH; Pyon, JK; Bang, SI; Lee, JE; Nam, SJ

Aberrant Lymphatic Drainage in the Contralateral Axilla in Patients with Isolated Ipsilateral Breast Tumor Recurrence

Ryu¹, JM; Chae, BJ; Lee, JE; Yu, J; Nam, SJ; Kim, SW; Lee, SK

Prognosis of BRCA1/2-negative breast cancer patients with HBOC risk factors compared with sporadic breast cancer patients without HBOC risk factors

Ryu¹, JM; Nam, SJ; Kim, SW; Lee, JE; Chae, BJ; Lee, SK; Yu, J

Oncologic Outcomes of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Patients with Tumor-Nipple Distance Less than 2.0 cm

Alsharif¹, E; Ryu, JM; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Chae, BJ; Lee, SK; Lee, JE

Insights Into Breast Cancer in the East vs the West: A Review

Yap¹, YS; Lu, YS; Tamura, K; Lee, JE; Ko, EY; Park, YH; Cao, AY; Lin, CH; Toi, M; Wu, J; Lee, SC

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, JE; Lee, SK

Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer

Kwon¹, MJ; Lee, JE; Jeong, J; Woo, SU; Han, J; Kang, BI; Kim, JE; Moon, Y; Lee, SB; Lee, S; Choi, YL; Kwon, Y; Song, K; Gong, G; Shin, YK

Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study

Lee¹, HM; Kim, BW; Park, S; Park, S; Lee, JE; Choi, YJ; Kim, SY; Woo, SU; Youn, HJ; Lee, I

Radiomics signature on 3T dynamic contrast-enhanced magnetic resonance imaging for estrogen receptor-positive invasive breast cancers Preliminary results for correlation with Oncotype DX recurrence scores

Nam¹, KJ; Park, H; Ko, ES; Lim, Y; Cho, HH; Lee, JE

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

Jung¹, J; Han, W; Lee, ES; Jung, SY; Han, JH; Noh, DY; Kim, Y; Choi, HJ; Lee, JE; Nam, SJ; Lee, JW; Kim, HJ; Um, E; Kim, JH; Park, S; Cho, YU

Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance

Kim¹, HK; Park, KH; Kim, Y; Park, SE; Lee, HS; Lim, SW; Cho, JH; Kim, JY; Lee, JE; Ahn, JS; Im, YH; Yu, JH; Park, YH

Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer

Choi¹, HJ; Ryu, JM; Kim, I; Nam, SJ; Kim, SW; Yu, JH; Lee, JE; Lee, SK

Permanent Chemotherapy-Induced Alopecia in Patients with Breast Cancer: A 3-Year Prospective Cohort Study

Kang¹, D; Kim, IR; Choi, EK; Im, YH; Park, YH; Ahn, JS; Lee, JE; Nam, SJ; Lee, HK; Park, JH; Lee, DY; Lacouture, ME; Guallar, E; Cho, J

TP53 upregulates -smooth muscle actin expression in tamoxifen-resistant breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment

Kwon¹, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY

A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer?

Lee¹, SK; Kim, SW; Yu, JH; Lee, JE; Kim, JY; Woo, J; Lee, S; Kim, EK; Moon, HG; Ko, SS; Nam, SJ

A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients

Hwang¹, HW; Jung, H; Hyeon, J; Park, YH; Ahn, JS; Im, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Choi, M; Cho, SY; Cho, EY

Serum Trace Elements and Their Associations with Breast Cancer Subgroups in Korean Breast Cancer Patients

Choi¹, R; Kim, MJ; Sohn, I; Kim, S; Kim, I; Ryu, JM; Choi, HJ; Kim, JM; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Lee, SY

The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans

Kim¹, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY

Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Ryu¹, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW

Only estrogen receptor "positive" is not enough to predict the prognosis of breast cancer

Ryu¹, JM; Choi, HJ; Kim, I; Lee, SK; Yu, J; Kim, JE; Kang, B; Lee, JE; Nam, SJ; Kim, SW

Formation of size-controllable tumour spheroids using a microfluidic pillar array (mu FPA) device

Lim¹, W; Hoang, HH; You, D; Han, J; Lee, JE; Kim, S; Park, S

Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis

Choi¹, HJ; Kim, I; Alsharif, E; Park, S; Kim, JM; Ryu, JM; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Prognostic value of immunohistochemically detected p53 in adjuvant chemotherapy-treated triple negative breast cancer

Bae¹, SY; Jung, SP; Lee, SK; Yu, J; Lee, JE; Kim, SW; Nam, SJ

Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort

Lee¹, JS; Oh, S; Park, SK; Lee, MH; Lee, JW; Kim, SW; Son, BH; Noh, DY; Lee, JE; Park, HL; Kim, MJ; Cho, SI; Lee, YK; Park, SS; Seong, MW

Patterns of Axillary Lymph Node Metastasis in Breast Cancer: A Prospective Single-Center Study

Choi¹, HJ; Kum, JM; Ryu, JM; Kim, I; Nam, SJ; Yu, J; Lee, SK; Lee, JE; Kim, SW

Berberine down-regulates IL-8 expression through inhibition of the EGFR/ MEK/ERK pathway in triple-negative breast cancer cells

Kim¹, S; You, D; Jeong, Y; Yu, J; Kim, SW; Nam, SJ; Lee, JE

BCT score predicts chemotherapy benefit in Asian patients with hormone receptor- positive, HER2-negative, lymph node-negative breast cancer

Kwon¹, MJ; Lee, SB; Han, J; Lee, JE; Lee, JW; Gong, G; Beitsch, PD; Nem, SJ; Ahn, SH; Nam, BH; Shin, YK

Prediction of ovarian function recovery in young breast cancer patients after protection with gonadotropin-releasing hormone agonist during chemotherapy

Lee¹, DY; Park, YH; Lee, JE; Choi, D

Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer

Park¹, H; Lim, Y; Ko, ES; Cho, HH; Lee, JE; Han, BK; Ko, EY; Choi, JS; Park, KW

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy

Lee¹, JK; Liu, ZQ; Sa, JK; Shin, S; Wang, JG; Bordyuh, M; Cho, H; Elliott, O; Chu, T; Choi, SW; Rosenbloom, DIS; Lee, IH; Shin, YJ; Kang, HJ; Kim, D; Kim, SY; Sim, MH; Kim, J; Lee, T; Seo, YJ; Shin, H; Lee, M; Kim, SH; Kwon, YJ; Oh, JW; Song, M; Kim, M; Kong, DS; Choi, JW; Seol, HJ; Lee, JI; Kim, ST; Park, JO; Kim, KM; Song, SY; Lee, JW; Kim, HC; Lee, JE; Choi, MG; Seo, SW; Shim, YM; Zo, JI; Jeong, BC; Yoon, Y; Ryu, GH; Kim, NKD; Bae, JS; Park, WY; Lee, J; Verhaak, RGW; Iavarone, A; Lee, J; Rabadan, R; Nam, DH

Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy

Kim¹, HJ; Lee, MH; Lee, JE; Park, S; Lee, ES; Kang, YJ; Shin, HN; Kim, SI; Lee, JH; Im, SA; Ahn, SH; Lee, KS; Sohn, J; Kim, S; Nam, SJ; Han, W

Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment

Cho¹, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S

Validation of the new AJCC eighth edition of the TNM classification for breast cancer with a single-center breast cancer cohort

Kim¹, JY; Lim, JE; Jung, HH; Cho, SY; Cho, EY; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ; Park, YH; Ahn, JS; Im, YH

Clinical Characteristics and Prognosis of Pregnancy-Associated Breast Cancer: Poor Survival of Luminal B Subtype

Bae¹, SY; Jung, SP; Jung, ES; Park, SM; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Preoperative Axillary US in Early-Stage Breast Cancer: Potential to Prevent Unnecessary Axillary Lymph Node Dissection

Kim¹, GR; Choi, JS; Han, BK; Lee, JE; Nam, SJ; Ko, EY; Ko, ES; Lee, SK

Prognostic Validation of the American Joint Committee on Cancer 8th Staging System in 24,014 Korean Patients with Breast Cancer

Kim¹, I; Choi, HJ; Ryu, JM; Lee, SK; Yu, JH; Kim, SW; Nam, SJ; Lee, JE

Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy?

Cho¹, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY

Verification of a Western Nomogram for Predicting Oncotype DX (TM) Recurrence Scores in Korean Patients with Breast Cancer

Kim¹, JM; Ryu, JM; Kim, I; Choi, HJ; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Lee, JE

Association between mammographic density and tumor marker-defined breast cancer subtypes: a case-control study

Shin¹, J; Lee, JE; Ko, HY; Nguyen, TL; Nam, SJ; Hopper, JL; Song, YM

Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer

Park¹, S; Lee, JE; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Yu, J; Kim, SW; Nam, SJ

Multi-omics profiling of younger Asian breast cancers reveals distinctive molecular signatures

Kan¹, ZY; Ding, Y; Kim, J; Jung, HH; Chung, W; Lal, S; Cho, S; Fernandez-Banet, J; Lee, SK; Kim, SW; Lee, JE; Choi, YL; Deng, S; Kim, JY; Ahn, JS; Sha, Y; Mu, XJ; Nam, JY; Im, YH; Lee, S; Park, WY; Nam, SJ; Park, YH

Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer

Nam¹, SY; Ko, ES; Lim, Y; Han, BK; Ko, EY; Choi, JS; Lee, JE

Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells

Jeong¹, Y; You, D; Kang, HG; Yu, J; Kim, SW; Nam, SJ; Lee, JE; Kim, S

Breast Cancer Epidemiology of the Working-Age Female Population Reveals Significant Implications for the South Korean Economy

Park¹, JH; Lee, SK; Lee, JE; Kim, SW; Nam, SJ; Kim, JY; Ahn, JS; Park, W; Yu, J; Park, YH

Genetic and Clinical Characteristics of Phyllodes Tumors of the Breast

Kim¹, JY; Yu, JH; Nam, SJ; Kim, SW; Lee, SK; Park, WY; Noh, DY; Nam, DH; Park, YH; Han, W; Lee, JE

Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane

Park¹, S; Lee, JE; Yu, J; Paik, HJ; Ryu, JM; Kim, I; Bae, SY; Lee, SK; Kim, SW; Nam, SJ; Kim, EK; Kang, E; Yang, EJ

Berberine Suppresses Cell Motility Through Downregulation of TGF-beta 1 in Triple Negative Breast Cancer Cells

Kim¹, S; Lee, J; You, D; Jeong, Y; Jeon, M; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Development and validation of the smart management strategy for health assessment tool-short form (SAT-SF) in cancer survivors

Yun¹, YH; Jung, JY; Sim, JA; Lee, J; Noh, DY; Han, W; Park, KJ; Jeong, SY; Park, JW; Wu, HG; Chie, EK; Kim, HJ; Jung, KH; Zo, JI; Kim, S; Lee, JE; Nam, SJ; Lee, ES; Oh, JH; Kim, YW; Kim, YT; Shim, YM

SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells

Han¹, KY; Kim, KT; Joung, JG; Son, DS; Kim, YJ; Jo, A; Jeon, HJ; Moon, HS; Yoo, CE; Chung, W; Eum, HH; Kim, S; Kim, HK; Lee, JE; Ahn, MJ; Lee, HO; Park, D; Park, WY

A train the trainer program for healthcare professionals tasked with providing psychosocial support to breast cancer survivors

Park¹, E; Yoon, J; Choi, EK; Kim, IR; Kang, D; Lee, SK; Lee, JE; Nam, SJ; Ahn, JS; Visser, A; Cho, J

Different prognosis of young breast cancer patients in their 20s and 30s depending on subtype: a nationwide study from the Korean Breast Cancer Society

Ryu¹, JM; Yu, J; Kim, SI; Kim, KS; Moon, HG; Choi, JE; Jeong, J; Byun, KD; Nam, SJ; Lee, JE; Lee, SK; Kim, SW

Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells

You¹, D; Jung, SP; Jeong, Y; Bae, SY; Lee, JE; Kim, S

Variations in plasma concentrations of tamoxifen metabolites and the effects of genetic polymorphisms on tamoxifen metabolism in Korean patients with breast cancer

Woo¹, HI; Lee, SK; Kim, J; Kim, SW; Yu, J; Bae, SY; Lee, JE; Nam, SJ; Lee, SY

Who are happy survivors? Physical, psychosocial, and spiritual factors associated with happiness of breast cancer survivors during the transition from cancer patient to survivor

Kang¹, D; Kim, IR; Choi, EK; Yoon, JH; Lee, SK; Lee, JE; Nam, SJ; Han, W; Noh, DY; Cho, J

Prevalence and detection of low-allele-fraction variants in clinical cancer samples

Shin¹, HT; Choi, YL; Yun, JW; Kim, NKD; Kim, SY; Jeon, HJ; Nam, JY; Lee, C; Ryu, D; Kim, SC; Park, K; Lee, E; Bae, JS; Son, DS; Joung, JG; Lee, J; Kim, ST; Ahn, MJ; Lee, SH; Ahn, JS; Lee, WY; Oh, BY; Park, YH; Lee, JE; Lee, KH; Kim, HC; Kim, KM; Im, YH; Park, K; Park, PJ; Park, WY

Predictive Factors for Nonsentinel Lymph Node Metastasis in Patients With Positive Sentinel Lymph Nodes After Neoadjuvant Chemotherapy: Nomogram for Predicting Nonsentinel Lymph Node Metastasis

Ryu¹, JM; Lee, SK; Kim, JY; Yu, JH; Kim, SW; Lee, JE; Han, SH; Jung, YS; Nam, SJ

Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy

Kang¹, YJ; Han, W; Park, S; You, J; Yi, HW; Park, S; Nam, S; Kim, JH; Yun, KW; Kim, HJ; Ahn, SH; Park, S; Lee, JE; Lee, ES; Noh, DY; Lee, JW

Circulating tumor DNA shows variable clonal response of breast cancer during neoadjuvant chemotherapy

Kim¹, JY; Park, D; Son, DS; Nam, SJ; Kim, SW; Jung, HH; Kim, YJ; Park, G; Park, WY; Lee, JE; Park, YH

Comparison of Core Needle Biopsy and Surgical Specimens in Determining Intrinsic Biological Subtypes of Breast Cancer with Immunohistochemistry

You¹, K; Park, S; Ryu, JM; Kim, I; Lee, SK; Yu, J; Kim, SW; Nam, SJ; Lee, JE

Development of a Nomogram to Predict N2 or N3 Stage in T1-2 Invasive Breast Cancer Patients with No Palpable Lymphadenopathy

Kim¹, I; Ryu, JM; Kim, JM; Choi, HJ; Lee, SK; Yu, JH; Lee, JE; Kim, SW; Nam, SJ

Dimerization of EGFR and HER2 induces breast cancer cell motility through STAT1-dependent ACTA2 induction

Jeon¹, M; You, D; Bae, SY; Kim, SW; Nam, SJ; Kim, HH; Kim, S; Lee, JE

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

Kim¹, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer

Han¹, J; Choi, YL; Kim, H; Choi, JY; Lee, SK; Lee, JE; Choi, JS; Park, S; Choi, JS; Kim, YD; Nam, SJ; Nam, BH; Kwon, MJ; Shin, YK

Agoraphobia and Follicle-Stimulating Hormone Levels between Tamoxifen and Goserelin versus Tamoxifen Alone in Premenopausal Hormone Receptor-Positive Breast Cancer: A 12-Month Prospective Randomized Study

Heo¹, JY; Yi, H; Fava, M; Mischoulon, D; Kim, K; Yoon, S; Jeon, HJ; Lee, JE

A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer

Gong G1¹, Kwon MJ2,3, Han J4, Lee HJ1, Lee SK5, Lee JE5, Lee SH6, Park S7, Choi JS7, Cho SY8, Ahn SH9, Lee JW9, Cho SR4, Moon Y4, Nam BH10, Nam SJ5, Choi YL8,11,12, Shin YK7,13,14.

Fertility Rates in Young Korean Breast Cancer Patients Treated with Gonadotropin-Releasing Hormone and Chemotherapy

Kim I1¹, Ryu JM1, Paik HJ1, Park S1, Bae SY1, Lee SK1, Yu J1, Kim SW1, Nam SJ1, Lee JE1.

Oncologic Outcomes after Immediate Breast Reconstruction Following Total Mastectomy in Patients with Breast Cancer: A Matched Case-Control Study

Ryu JM1¹, Paik HJ1, Park S1, Yi HW1, Nam SJ1, Kim SW1, Lee SK1, Yu J1, Bae SY1, Lee JE1.

Tumor-associated macrophages (TAMs) and tumor-infiltrating lymphocytes (TILs) in pretherapeutic breast cancer core biopsies: Anti-tumoral effect of immune cells associated with neoadjuvant chemotherapy

Yoon N¹, Han KM, Cho SY, Kim SW, Lee JE, Nam SJ, Cho EY

Feasibility and Prognostic Effect of Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Cytology-Proven, Node-Positive Breast Cancer

Park S1¹, Lee JE2, Paik HJ1, Ryu JM1, Bae SY1, Lee SK1, Kim SW1, Nam SJ1.

Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer

Kim H1¹, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.

Conditional disease-free survival among patients with breast cancer

Paik HJ1¹, Lee SK, Ryu JM, Park S, Kim I, Bae SY, Yu J, Lee JE, Kim SW, Nam SJ.

Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype

Alramadhan M1¹, Ryu JM1, Rayzah M1, Nam SJ1, Kim SW1, Yu J1, Lee SK1, Bae SY1, Park S1, Paik HJ1, Lee JE2.

Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society

Ryu JM1¹, Lee HJ2, Yoon TI3, Lee ES4, Lee SJ5, Jung JH6, Chae BJ7, Nam SJ1, Lee JE1, Lee SK1, Bae SY1, Yu J1, Kim SW8; Korean Breast Cancer Society Consortium.

Elevated IL-1 beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone

Jeon M1¹, Han J2, Nam SJ2, Lee JE3, Kim S4.

Body Mass Index with Tumor F-18-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer

Hyun SH1¹, Ahn HK2, Lee JH1, Choi JY1, Kim BT1, Park YH3, Im YH3, Lee JE4, Nam SJ4, Lee KH1.

Clinicopathologic Features and Long-Term Outcomes of Elderly Breast Cancer Patients: Experiences at a Single Institution in Korea

Kim HK1¹, Ham JS1, Byeon S1, Yoo KH1, Jung KS1, Song HN1, Cho J1, Lee JY1, Lim SH1, Kim HS1, Kim JY1, Lee JE2, Kim SW2, Nam SJ2, Lee SK2, Bae SY2, Ahn JS1, Im YH1, Park YH1.

Radiologic Findings of Primary Mucinous Cystadenocarcinoma of the Breast: A Report of Two Cases and a Literature Review

Seong M1¹, Ko EY1, Han BK1, Cho SY2, Cho EY2, Lee SK3, Lee JE3.

Clinicopathological Features and Prognostic Factors Affecting Survival Outcomes in Isolated Locoregional Recurrence of Breast Cancer: Single-Institutional Series

Lee MY1¹, Chang WJ1, Kim HS1, Lee JY1, Lim SH1, Lee JE2, Kim SW2, Nam SJ2, Ahn JS1, Im YH1, Park YH1.

STC-1 expression is upregulated through an Akt/NF-B-dependent pathway in triple-negative breast cancer cells

Jeon M1¹, Han J1, Nam SJ1, Lee JE1, Kim S1.

Feasibility of Nipple-Sparing Mastectomy with Immediate Breast Reconstruction in Breast Cancer Patients with Tumor-Nipple Distance Less Than 2.0 cm

Ryu JM1¹, Nam SJ1, Kim SW1, Lee SK1, Bae SY1, Yi HW1, Park S1, Paik HJ1, Lee JE2.

The relationship between nuclear factor (NF)-kappa B family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment

Kim JY¹, Jung HH, Ahn S, Bae S, Lee SK, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-beta 2 expression

Kim S1¹, Han J2, Jeon M2,3, You D2,3, Lee J2, Kim HJ2, Bae S2, Nam SJ2, Lee JE4,5.

Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer

Kim H1¹, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.

Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Frequency of MED12 mutations in phyllodes tumors: Inverse correlation with histologic grade

Yoon N1¹, Bae GE2, Kang SY1, Choi MS1, Hwang HW1, Kim SW3, Lee JE3, Nam SJ3, Gong G4, Lee HJ4, Bae YK5, Lee A6, Cho EY1.

Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes

Kim SW1¹, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.

MEK activity controls IL-8 expression in tamoxifen-resistant MCF-7 breast cancer cells

Kim S1¹, Jeon M1, Lee JE1, Nam SJ1.

Characterization of Korean Male Breast Cancer Using an Online Nationwide Breast-Cancer Database Matched-Pair Analysis of Patients With Female Breast Cancer

Choi MY1¹, Lee SK, Lee JE, Park HS, Lim ST, Jung Y, Ko BK, Nam SJ; Korean Breast Cancer Society.

MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells

Kim S1¹, Lee J2, Jeon M2,3, Lee JE2,3, Nam SJ4.

Prognostic value of ERBB4 expression in patients with triple negative breast cancer

Kim JY1¹, Jung HH2, Do IG3, Bae S4, Lee SK5, Kim SW6, Lee JE7, Nam SJ8, Ahn JS9, Park YH10,11, Im YH12,13.

Zerumbone suppresses the motility and tumorigenecity of triple negative breast cancer cells via the inhibition of TGF-beta 1 signaling pathway

Kim S1¹, Lee J1, Jeon M1,2, Lee JE1,2, Nam SJ1.

Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer

Lee JY1¹, Park K2, Lim SH1, Kim HS1, Yoo KH1, Jung KS1, Song HN1, Hong M3, Do IG3, Ahn T2, Lee SK4, Bae SY4, Kim SW4, Lee JE4, Nam SJ4, Kim DH5, Jung HH6, Kim JY1, Ahn JS1, Im YH1, Park YH1.

Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments

Yu JI1¹, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.

Independent Prognostic Factors for Overall Survival after Salvage Operation for Ipsilateral Breast Tumor Recurrence Following Breast-Conserving Surgery

Lee JH1¹, Lee SK1, Park SM1, Ryu JM1, Paik HJ1, Yi HW1, Bae SY1, Lee JE1, Kim SW1, Nam SJ1.

Patient-reported assessment of self-management strategies of health in cancer patients: development and validation of the Smart Management Strategy for Health Assessment Tool (SAT)

Yun YH1¹,2, Jung JY1, Sim JA1, Choi H1, Lee JM3, Noh DY2,4, Han W2,4, Park KJ4, Jeong SY4, Park JW4, Wu HG5, Chie EK5, Kim HJ5, Lee JH6, Zo ZI7, Kim S8, Lee JE8, Nam SJ8, Lee ES3, Oh JH3, Kim YW3, Kim YT2,9, Shim YM7.

The Value of Ki67 in Very Young Women with Hormone Receptor-Positive Breast Cancer: Retrospective Analysis of 9,321 Korean Women

Kim J1¹, Han W2, Jung SY3, Park YH4, Moon HG5, Ahn SK6, Lee JW7, Kim MK5, Kim JJ5, Lee ES5, You TK1, Kang HS3, Lee ES3, Ro J3, Lee JE4, Nam SJ4, Yim YH4, Park IA5, Noh DY5.

Impact on Survival of Regular Postoperative Surveillance for Patients with Early Breast Cancer

Lee JY1¹, Lim SH1, Lee MY1, Kim H1, Kim M1, Kim S1, Jung HA1, Sohn I2, Gil WH3, Lee JE3, Kim SW3, Nam SJ3, Ahn JS1, Im YH1, Park YH1.

Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients

Park JS1¹, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.

Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation

Kim H1¹, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.

Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast

Park JS1¹, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.

Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells

Kim S1¹, Lee J1, Oh SJ1, Nam SJ1, Lee JE1.

Elevated TGF-beta 1 and -beta 2 expression accelerates the epithelial to mesenchymal transition in triple-negative breast cancer cells

Kim S1¹, Lee J2, Jeon M3, Nam SJ2, Lee JE4.

Mammographic density and risk of breast cancer in Korean women

Kim BK1¹, Choi YH, Nguyen TL, Nam SJ, Lee JE, Hopper JL, Sung J, Song YM.

Molecular characterization of patients with pathologic complete response or early failure after neoadjuvant chemotherapy for locally advanced breast cancer using next generation sequencing and nCounter assay

Park K1¹, Choi MK2, Jung HH3, Do IG4, Lee KH5, Ahn T1, Kil WH6, Kim SW6, Lee JE6, Nam SJ6, Kim DH7, Ahn JS2, Im YH2,3, Park YH2,3.

Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival

Lee SK1¹, Bae SY1, Lee JH1, Lee HC1, Yi H1, Kil WH1, Lee JE1, Kim SW1, Nam SJ1.

Quantitative changes in skin composition parameters due to chemotherapy in breast cancer patients: a cohort study

Kang D1¹, Kim IR, Im YH, Park YH, Ahn JS, Lee JE, Nam SJ, Park H, Kim E, Lee HK, Lee DY, Cho J.

Preoperative Magnetic Resonance Imaging-Based Breast Volumetry for Immediate Breast Reconstruction

Kim H1¹, Mun GH, Wiraatmadja ES, Lim SY, Pyon JK, Oh KS, Lee JE, Nam SJ, Bang SI.

Prevalence and clinical outcomes of young breast cancer (YBC) patients according to intrinsic breast cancer subtypes: Single institutional experience in Korea

Park YH1¹, Lee SJ1, Jung HA1, Kim SM1, Kim MJ1, Kil WH2, Lee JE2, Nam SJ2, Ahn JS1, Im YH3.

Is Holm Zone III safe from fat necrosis in medial row perforator-based deep inferior epigastric perforator flaps

Lee KT1¹, Lee JE2, Nam SJ2, Han BK3, Mun GH1.

Immediate Postoperative Inflammation Is an Important Prognostic Factor in Breast Cancer

Lee SK1¹, Choi MY, Bae SY, Lee JH, Lee HC, Kil WH, Lee JE, Kim SW, Nam SJ.

The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population: recent update of the Korean Hereditary Breast Cancer (KOHBRA) study

Kang E1¹, Seong MW, Park SK, Lee JW, Lee J, Kim LS, Lee JE, Kim SY, Jeong J, Han SA, Kim SW; Korean Hereditary Breast Cancer Study Group.

Induction of fibronectin by HER2 overexpression triggers adhesion and invasion of breast cancer cells

Jeon M1¹, Lee J2, Nam SJ2, Shin I3, Lee JE4, Kim S5.

Surgery of primary tumour has survival benefit in metastatic breast cancer with single-organ metastasis, especially bone

Rhu J¹, Lee SK, Kil WH, Lee JE, Nam SJ.

The Clinical Impact of 21-Gene Recurrence Score on Treatment Decisions for Patients with Hormone Receptor-Positive Early Breast Cancer in Korea

Lee MH1¹, Han W2, Lee JE3, Kim KS4, Park H5, Kim J2, Bae SY3, Shin HJ4, Lee JW5, Lee ES1.

A seven-gene signature can predict distant recurrence in patients with triple- negative breast cancers who receive adjuvant chemotherapy following surgery

Park YH1¹, Jung HH, Do IG, Cho EY, Sohn I, Jung SH, Kil WH, Kim SW, Lee JE, Nam SJ, Ahn JS, Im YH.

Volume-based Metabolic Tumor Response to Neoadjuvant Chemotherapy Is Associated with an Increased Risk of Recurrence in Breast Cancer

Hyun SH1¹, Ahn HK, Park YH, Im YH, Kil WH, Lee JE, Nam SJ, Cho EY, Choi JY.

Lateral neck sentinel lymph node biopsy in papillary thyroid carcinoma, is it really necessary A randomized, controlled study

Lee SK1¹, Lee JH1, Bae SY1, Kim J1, Kim M1, Lee HC1, Jung YY2, Kil WH1, Kim SW1, Lee JE1, Nam SJ1, Choe JH1, Kim JH1, Kim JS3.

Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer

Yu JI1¹, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.

Sentinel Lymph Node Biopsy Alone after Neoadjuvant Chemotherapy in Patients with Initial Cytology-Proven Axillary Node Metastasis

Kim JY1¹, Kim MK2, Lee JE3, Jung Y1, Bae SY3, Lee SK3, Kil WH3, Kim SW3, Kim KS4, Nam SJ3, Han S1.

Poor prognosis of single hormone receptor-positive breast cancer: similar outcome as triple-negative breast cancer

Bae SY1¹, Kim S2, Lee JH3, Lee HC4, Lee SK5, Kil WH6, Kim SW7, Lee JE8, Nam SJ9.

Prognostic relevance of biological subtype overrides that of TNM staging in breast cancer: discordance between stage and biology

Jung HA1¹, Park YH, Kim M, Kim S, Chang WJ, Choi MK, Hong JY, Kim SW, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Zerumbone suppresses EGF-induced CD44 expression through the inhibition of STAT3 in breast cancer cells

Kim S1¹, Kil WH1, Lee J1, Oh SJ1, Han J1, Jeon M1, Jung T1, Lee SK1, Bae SY1, Lee HC1, Lee JH1, Yi HW1, Kim SW1, Nam SJ1, Lee JE1.

Invasive Paget disease of the breast: 20 years of experience at a single institution

Lee HW1¹, Kim TE1, Cho SY1, Kim SW2, Kil WH2, Lee JE2, Nam SJ2, Cho EY3.

Induction of fibronectin in response to epidermal growth factor is suppressed by silibinin through the inhibition of STAT3 in triple negative breast cancer cells

Kim S1¹, Jeon M1, Lee J1, Han J1, Oh SJ1, Jung T1, Nam SJ1, Kil WH1, Lee JE1.

Zerumbone Suppresses IL-1 beta-induced Cell Migration and Invasion by Inhibiting IL-8 and MMP-3 Expression in Human Triple-negative Breast Cancer Cells

Han J1¹, Bae SY, Oh SJ, Lee J, Lee JH, Lee HC, Lee SK, Kil WH, Kim SW, Nam SJ, Kim S, Lee JE.

Association between Socioeconomic Status and Altered Appearance Distress, Body Image, and Quality of Life Among Breast Cancer Patients

Chang O1¹, Choi EK, Kim IR, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Cho J.

Ovarian function preservation with GnRH agonist in young breast cancer patients: Does it impede the effect of adjuvant chemotherapy

Kim J1¹, Kim M2, Lee JH2, Lee H2, Lee SK2, Bae SY2, Jun SY3, Kil WH2, Lee JE4, Kim SW2, Nam SJ2.

Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients

Choi EK1¹, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, Lee SK, Im YH, Park YH, Yang JH, Cho J.

Excision alone for small size ductal carcinoma in situ of the breast

Kim H1¹, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.

Anticancer effect of silibinin on the xenograft model using MDA-MB-468 breast cancer cells

Kil WH1¹, Kim SM1, Lee JE1, Park KS2, Nam SJ1.

Breast Cancer Screening Knowledge and Perceived Health Beliefs among Immigrant Women in Korea

Kim J1¹, Lee SK2, Lee J3, Choi MY3, Jung SP4, Kim MK2, Kim S2, Nam SJ2, Lee JE2, Kil WH2.

Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy

Kil WH1¹, Lee JE1, Nam SJ1.

Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer

Choi MK1¹, Park YH, Kil WH, Lee JE, Nam SJ, Ahn JS, Im YH.

Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines

Kim SH1¹, Lee HY2, Jung SP2, Kim S3, Lee JE3, Nam SJ3, Bae JW2.

A multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients

Seong MW1¹, Kim KH, Chung IY, Kang E, Lee JW, Park SK, Lee MH, Lee JE, Noh DY, Son BH, Park HL, Cho SI, Park SS; Korean Hereditary Breast Cancer Study Group, Kim SW.

Aberrant DNA methylation of integrin alpha 4 in human breast cancer

Do SI1¹, Ko E, Kang SY, Lee JE, Nam SJ, Cho EY, Kim DH.

Validation and Comparison of CS-IHC4 Scores with a Nomogram to Predict Recurrence in Hormone Receptor-Positive Breast Cancers

Park YH1¹, Im SA, Cho EY, Ahn JH, Woo SY, Kim S, Keam B, Lee JE, Han W, Nam SJ, Park IA, Noh DY, Yang JH, Ahn JS, Im YH.

Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection

Noh JM1¹, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.

The Protective Effect of Parity in Hormone Receptor-Positive, Ki-67 Expressing Breast Cancer

Lee SK1¹, Kim SW, Han SA, Kil WH, Lee JE, Nam SJ.

Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population

Noh JM1¹, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.

Protein kinase C- a downregulates estrogen receptor- a by suppressing c- Jun phosphorylation in estrogen receptor- positive breast cancer cells

Kim S1¹, Lee J1, Lee SK1, Bae SY1, Kim J1, Kim M1, Kil WH1, Kim SW1, Lee JE1, Nam SJ1.

Polyostotic Fibrous Dysplasia Mimicking Multiple Bone Metastases in a Patient with Ductal Carcinoma In Situ

Lee JH1¹, Kim SY2, Lee JE1, Cho EY3, Choi YL3, Choi JY4, Han SW2, Kim SW1, Kil WH1, Nam SJ1.

Development and validation of Chemotherapy-induced Alopecia Distress Scale (CADS) for breast cancer patients

Cho J1¹, Choi EK, Kim IR, Im YH, Park YH, Lee S, Lee JE, Yang JH, Nam SJ.

Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations

Park H1¹, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.

Primary Follicular Lymphoma in a Male Breast: A Case Report

Jung SP1¹, Han KM2, Kim SJ3, Nam SJ4, Bae JW1, Lee JE4.

Berberine Suppresses TPA-Induced Fibronectin Expression through the Inhibition of VEGF Secretion in Breast Cancer Cells

Kim S1¹, Oh SJ, Lee J, Han J, Jeon M, Jung T, Lee SK, Bae SY, Kim J, Gil WH, Kim SW, Lee JE, Nam SJ.

Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma

Park I1¹, Kim J1, Kim M1, Bae SY1, Lee SK1, Kil WH1, Lee JE1, Nam SJ1.

Round Block Technique Without Cerclage in Breast-Conserving Surgery

Kim MK1¹, Kim J, Jung SP, Bae SY, Choi MY, Lee SK, Kim S, Kil WH, Kim SW, Kim JH, Kim JS, Nam SJ, Lee JE.

Breast Metastasis from Rhabdomyosarcoma of the Anus in an Adolescent Female

Jung SP1¹, Lee Y, Han KM, Lee SK, Kim S, Bae SY, Kim J, Kim M, Kim S, Kil WH, Koo HH, Nam SJ, Bae JW, Lee JE.

Experience of treatment of patients with granulomatous lobular mastitis

Hur SM1¹, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.

HER3 status by immunohistochemistry is correlated with poor prognosis in hormone receptor-negative breast cancer patients

Bae SY1¹, La Choi Y, Kim S, Kim M, Kim J, Jung SP, Choi MY, Lee SK, Kil WH, Lee JE, Nam SJ.

Neoadjuvant human epidermal growth factor receptor-2 targeted therapy in patients with locally advanced breast cancer

Cho DH1¹, Lee SK, Kim S, Choi MY, Jung SP, Lee J, Kim J, Koo MY, Bae SY, Kim JH, Kim JS, Ho KW, Lee JE, Nam SJ, Yang JH.

Primary breast lymphoma: a single institution's experience

Jung SP1¹, Kim M, Han KM, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

Validation of a Web-Based Tool to Predict the Ipsilateral Breast Tumor Recurrence (IBTR! 2.0) after Breast-Conserving Therapy for Korean Patients

Jung SP1¹, Hur SM, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim MK, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ, Bae JW, Lee JE.

The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study

Han SA1¹, Kim SW, Kang E, Park SK, Ahn SH, Lee MH, Nam SJ, Han W, Bae YT, Kim HA, Cho YU, Chang MC, Paik NS, Hwang KT, Kim SJ, Noh DY, Choi DH, Noh WC, Kim LS, Kim KS, Suh YJ, Lee JE, Jung Y, Moon BI, Yang JH, Son BH, Yom CK, Kim SY, Lee H, Jung SH; KOHBRA Research Group and the Korean Breast Cancer Society.

Adjuvant Chemotherapy and Survival of Elderly Korean Patients with Breast Carcinoma

Jung SP1¹, Lee JE, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kil WH, Choe JH, Kim JH, Kim JS, Nam SJ.

Occult Breast Cancers Manifesting as Axillary Lymph Node Metastasis in Men: A Two-Case Report

Hur SM1¹, Cho DH, Lee SK, Choi MY, Bae SY, Koo MY, Kim S, Nam SJ, Lee JE, Yang JH.

Invasive Pleomorphic Lobular Carcinoma of the Breast: Clinicopathologic Characteristics and Prognosis Compared with Invasive Ductal Carcinoma

Jung SP1¹, Lee SK, Kim S, Choi MY, Bae SY, Kim J, Kim M, Kil WH, Cho EY, Choe JH, Kim JH, Kim JS, Nam SJ, Lee JE.

Accuracy of BRCA1/2 mutation prediction models in Korean breast cancer patients

Kang E1¹, Park SK, Yang JJ, Park B, Lee MH, Lee JW, Suh YJ, Lee JE, Kim HA, Oh SJ, Kim SW; Korean Breast Cancer Society.

A functional comparison between the HER2(high)/HER3 and the HER2l(ow/)HER3 dimers on heregulin-beta 1-induced MMP-1 and MMP-9 expression in breast cancer cells

Kim S1¹, Han J, Shin I, Kil WH, Lee JE, Nam SJ.

Clinicopathologic Risk Factors for the Local Recurrence of Phyllodes Tumors of the Breast

Jang JH1¹, Choi MY, Lee SK, Kim S, Kim J, Lee J, Jung SP, Choe JH, Kim JH, Kim JS, Cho EY, Lee JE, Nam SJ, Yang JH.

Berberine Suppresses the TPA-Induced MMP-1 and MMP-9 Expressions Through the Inhibition of PKC-alpha in Breast Cancer Cells

Kim S1¹, Han J, Lee SK, Choi MY, Kim J, Lee J, Jung SP, Kim JS, Kim JH, Choe JH, Lee JE, Nam SJ.

Development of Novel Breast Cancer Recurrence Prediction Model Using Support Vector Machine

Kim W1¹, Kim KS, Lee JE, Noh DY, Kim SW, Jung YS, Park MY, Park RW.

Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study

Son BH1¹, Ahn SH, Kim SW, Kang E, Park SK, Lee MH, Noh WC, Kim LS, Jung Y, Kim KS, Noh DY, Moon BI, Suh YJ, Lee JE, Choi DH, Kim SY, Jung SH, Yom CK, Lee H, Yang JH; KOHBRA Research Group and Korean Breast Cancer Society.

Perception, Attitudes, Preparedness and Experience of Chemotherapy-Induced Alopecia among Breast Cancer Patients: a Qualitative Study

Kim IR1¹, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, Nam SJ, Yang JH.

Spectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing

Jang JH1¹, Lee JE, Kwon MJ, Ki CS, Kim JW, Nam SJ, Yang JH.

Efficacy of an Educational Material on Second Primary Cancer Screening Practice for Cancer Survivors: A Randomized Controlled Trial

Shin DW1¹, Cho J, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Guallar E, Lee WC.

TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells

Han J1¹, Kim S, Yang JH, Nam SJ, Lee JE.

Comparison between screen-detected and symptomatic breast cancers according to molecular subtypes

Kim J1¹, Lee S, Bae S, Choi MY, Lee J, Jung SP, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Effect of berberine on p53 expression by TPA in breast cancer cells

Kim S1¹, Han J, Kim NY, Lee SK, Cho DH, Choi MY, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE.

Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells

Kim S1¹, Han J, Lee SK, Koo M, Cho DH, Bae SY, Choi MY, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

Mucinous Carcinoma of the Breast in Comparison with Invasive Ductal Carcinoma: Clinicopathologic Characteristics and Prognosis

Bae SY1¹, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.

Does Immediate Breast Reconstruction after Mastectomy affect the Initiation of Adjuvant Chemotherapy

Lee J1¹, Lee SK, Kim S, Koo MY, Choi MY, Bae SY, Cho DH, Kim J, Jung SP, Choe JH, Kim JH, Kim JS, Lee JE, Yang JH, Nam SJ.

Ileal Metastasis of Breast Cancer in a Patient with a BRCA2 Gene Mutation: Report of a Case

Cho DH1¹, Jeon YS, Choi MY, Lee SK, Kim SM, Hur SM, Koo MY, Bae SY, Choe JH, Kim JH, Kim JS, Nam SJ, Yang JH, Lee JE.

Silibinin Suppresses EGFR Ligand-induced CD44 Expression through Inhibition of EGFR Activity in Breast Cancer Cells

Kim S1¹, Han J, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

Large Clinical Experience of Primary Angiosarcoma of the Breast in a Single Korean Medical Institute

Bae SY1¹, Choi MY, Cho DH, Lee JE, Nam SJ, Yang JH.

Invited Commentary on: Can CD44+/CD24-Tumor Stem Cells Be Used to Determine the Extent of Breast Cancer Invasion Following Neoadjuvant Chemotherapy

Lee JE1¹, Nam SJ.

Results from Over One Year of Follow-Up for Absorbable Mesh Insertion in Partial Mastectomy

Koo MY1¹, Lee SK, Hur SM, Bae SY, Choi MY, Cho DH, Kim S, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Knowledge, Attitudes, Risk Perception, and Cancer Screening Behaviors Among Cancer Survivors

Shin DW1¹, Kim YW, Oh JH, Kim SW, Chung KW, Lee WY, Lee JE, Lee WC, Guallar E, Cho J.

Commentary on: Incidental Breast Cancers Identified in a One-Stop Symptomatic Breast Clinic

Lee JE1¹, Yang JH, Nam SJ.

The prognoses of metaplastic breast cancer patients compared to those of triple-negative breast cancer patients

Bae SY1¹, Lee SK, Koo MY, Hur SM, Choi MY, Cho DH, Kim S, Choe JH, Lee JE, Kim JH, Kim JS, Nam SJ, Yang JH.

Cases and Literature Review of Breast Sparganosis

Koo M1¹, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

The 70-Gene Prognostic Signature for Korean Breast Cancer Patients

Na KY1¹, Kim KS, Lee JE, Kim HJ, Yang JH, Ahn SH, Moon BI, Kim RM, Ko SM, Jung YS.

Survey of Psychosocial Problems Facing Breast Cancer Survivors after Undergoing a Mastectomy and Their Awareness of Breast Reconstruction

The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study

12-O-Tetradecanoyl phorbol-13-acetate (TPA)-induced growth arrest is increased by silibinin by the down-regulation of cyclin B1 and cdc2 and the up-regulation of p21 expression in MDA-MB231 human breast cancer cells

Kim S1¹, Lee HS, Lee SK, Kim SH, Hur SM, Kim JS, Kim JH, Choe JH, Shin I, Yang JH, Lee JE, Nam SJ.

Pifithrin-alpha an Inhibitor of p53 Transactivation, Up-Regulates COX-2 Expression through an MAPK-Dependent Pathway

Kim S1¹, Han J, Lee SK, Hur SM, Koo M, Cho DH, Bae SY, Choi MY, Shin I, Yang JH, Nam SJ, Lee JE.

Single-Port Access Laparoscopic Prophylactic Bilateral Salpingo-Oophorectomy in BRCA-Positive Breast Cancer Patient: A Case Report

Secondary Partial Mastectomy with Contralateral Sentinel Lymph Node Biopsy for Ipsilateral Breast Cancer Recurrence after Conservative Surgery: Report of 2 Cases

Incidental Detection of Ductal Carcinoma In Situ of the Breast from Bilateral Prophylactic Mastectomy of Asymptomatic BRCA2 Mutation Carrier: A Case Report

Biopsychosocial Predictors of the Quality of Life in Breast Cancer Patients

The Preoperative Role of Breast-specific Gamma Imaging for the Breast Cancer Patients: In Comparison with Conventional Imaging Modality

Characteristics of Invasive Micropapillary Carcinoma of the Breast: In Comparison with Invasive Ductal Carcinoma

Intracystic Papillary Carcinoma in the Male Breast

Characteristics of Metastasis in the Breast From Extramammary Malignancies

Lee SK1¹, Kim WW, Kim SH, Hur SM, Kim S, Choi JH, Cho EY, Han SY, Hahn BK, Choe JH, Kim JH, Kim JS, Lee JE, Nam SJ, Yang JH.

Implications of Isolated Tumor Cells in Sentinel Lymph Nodes of Breast Cancer Patients

Arm Sentinel Lymph Node Detection for Preserving the Arm Lymphatic System

Experience with Intracystic Papillary Carcinoma of the Breast at a Single Institute in Korea

Silibinin Suppresses TNF-alpha-Induced MMP-9 Expression in Gastric Cancer Cells through Inhibition of the MAPK Pathway

Kim S1¹, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, Hur SM, Kim JH, Choe JH, Nam SJ, Yang JH, Kim S, Lee JE, Kim JS.

Silibinin prevents TPA-induced MMP-9 expression by down-regulation of COX-2 in human breast cancer cells

Kim S1¹, Kim SH, Hur SM, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

Kim S1¹, Choi JH, Lim HI, Lee SK, Kim WW, Cho S, Kim JS, Kim JH, Choe JH, Nam SJ, Lee JE, Yang JH.

The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report

Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells

Kim S1¹, Choi JH, Lim HI, Lee SK, Kim WW, Kim JS, Kim JH, Choe JH, Yang JH, Nam SJ, Lee JE.

The Impact of the Ratio of Positive Nodes to Removed Nodes on Recurrence and Overall Survival in Node Positive Breast Cancer Patients

Martin FT1¹, O'Fearraigh C, Hanley C, Curran C, Sweeney KJ, Kerin MJ.

Berberine Suppresses TNF-alpha-induced MMP-9 and Cell Invasion through Inhibition of AP-1 Activity in MDA-MB-231 Human Breast Cancer Cells

Kim S1¹, Choi JH, Kim JB, Nam SJ, Yang JH, Kim JH, Lee JE.

Breast cancer stem cells: Changing therapeutic paradigm

Lee JE1¹, Yang JH, Nam SJ.

Analysis of prognostic factors and treatment modality changes in breast cancer: A single institution study in Korea

Lee WS1¹, Lee JE, Kim JH, Nam SJ, Yang JH.